Antibody Transfer
Antibody Transfer - Related Videos
13:21
Antibody Generation: Producing Monoclonal Antibodies Using Hybridomas
0 Views •
2023
Source: Frances V. Sjaastad1,2, Whitney Swanson2,3, and Thomas S. Griffith1,2,3,4 1 Microbiology, Immunology, and Cancer Biology Graduate Program, University of Minnesota, Minneapolis, MN 55455 2 Center for Immunology, University of Minnesota, Minneapolis, MN 55455 3 Department of Urology, University of Minnesota, Minneapolis, MN 55455 4 Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455 Polyclonal antibodies are defined as a collection of antibodies directed against...
12:55
Scalable High Throughput Selection From Phage-displayed Synthetic Antibody Libraries
0 Views •
Cited by 33 •
2015
A method is described with visual accompaniment for conducting scalable, high throughput selections from phage-displayed combinatorial synthetic antibody libraries against hundreds of antigens simultaneously. Using this parallel approach, we have isolated antibody fragments that exhibit high affinity and specificity for diverse antigens that are functional in standard immunoassays.
01:10
Antibody Structure
0 Views •
2019
Overview Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding. The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains Antibodies consist of four polypeptide chains: two identical heavy...
03:18
Antibody-Dependent Enhancement of Zika Virus by Dengue Antibodies in Human Primary Macrophages
0 Views •
2026
Source: Asad, S., et al. Quantification of Antibody-dependent Enhancement of the Zika Virus in Primary Human Cells. J. Vis. Exp. (2019)This video demonstrates antibody-dependent enhancement of Zika virus infection in human primary macrophages, using dengue antibody–virus complexes to model how cross-reactive antibodies facilitate Fcγ receptor–mediated viral entry and replication for studying infection mechanisms and immune interactions.
01:20
Transfer Pricing
0 Views •
2026
Transfer pricing is the process of setting prices for goods, services, or intangible assets exchanged between divisions, subsidiaries, or related entities within the same organization. Although these transactions occur within a single company, transfer prices are important for evaluating divisional performance, allocating resources, and supporting managerial decision-making. They affect the reported revenues, costs, and profitability of individual business units.Organizations use several...
FAQs
Maternal IgG crossing the placenta can provide a newborn with antigen-specific protection before the newborn independently produces antibodies. These immunoglobulins bind their matching antigens and can neutralize pathogens or toxins, creating early immune defense. This route makes placental transfer a central model for studying how maternal immunity supports protection during the neonatal period.
Breast milk provides another route through which antibodies can reach a newborn. Its importance lies in extending maternal immune protection beyond the placental pathway, allowing transferred immunoglobulins to participate in defense against matching antigens. Comparing milk-associated transfer with placental transfer helps clarify how different biological compartments contribute to maternal and neonatal immunity.
Transferred antibodies act through specific binding to antigens rather than providing nonspecific protection. Once an immunoglobulin recognizes its matching antigen, it can help neutralize a pathogen or toxin and support immune defense. The protective outcome therefore depends on which antibodies are transferred and whether their targets correspond to the infectious or toxic threat.
Antibody transfer supplies ready-made immunoglobulins, so the recipient does not need to produce those antibodies independently before receiving protection. This distinguishes passive protection from an immune process that depends on the recipient’s own antibody production. The distinction is important when interpreting temporary protection and when considering how antibody transfer relates to vaccine strategies.
Direct administration makes it possible to provide purified antibodies without relying on passage from a maternal source or across a biological barrier. In research and medicine, this approach extends the study and use of transferred immunity to controlled antibody delivery. Its effects can be considered through antigen binding, pathogen or toxin neutralization, and supported immune defense.
Studies of antibody transfer can focus on the route by which immunoglobulins move, including passage across the placenta, delivery through breast milk, or direct administration. Researchers also consider whether the transferred antibodies bind their intended antigens and support defense. These observations help explain maternal and neonatal immunity and the duration of passive protection.
Antibody transfer provides a framework for understanding how externally supplied immunoglobulins can protect against specific pathogens or toxins. That knowledge informs immunoglobulin therapies, while comparisons with recipient-generated immunity help guide vaccine strategies. The same scientific context connects maternal and neonatal protection with medical efforts to provide or stimulate effective immune defense.